Humana's stock has shown resilience, boosted by a 5% increase in Medicare Advantage payments. Read my analysis of HUM stock.

Humana shares jumped 11% in extended trading on Monday after the federal government said it would pay Medicare insurers more next year than previously expected. Monitor these key chart levels.

What Happened? Shares of health insurance company Humana (NYSE:HUM) fell 15.3% in the pre-market session after peer ...

The stock rose 11% to $283.50 in after-hours trading Monday. Below, we take a closer look at Humana’s chart and apply technical analysis to identify key price levels worth watching out for.

But Humana Inc.'s stock (HUM) rose more than 11% in Monday's after-hours action, while CVS Health Corp.'s stock (CVS) gained 6.5% and UnitedHealth Group Inc.'s stock (UNH) advanced nearly 6%.

But Humana Inc.'s stock (HUM) rose more than 11% in ... they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that ...

CVS stock fell from $80 per share to <$45 per share, and Humana stock from >$500 per share ... lies with drug pricing. Analysis - Despite Positive Guidance, UnitedHealth Stock Remains At Risk ...

Humana is part of the Health Care sector, which has an average P/E ratio of 26.07 and an average P/B of 3.53 Humana has on average reported free cash flows of $3.16 Billion over the last four years, ...

The cost of similar Covid-19 treatments can vary by tens of thousands of dollars a patient, even within the same hospital, according to a Wall Street Journal analysis of pricing data that ...